Predictive Discovery Limited (PREDQ)
Subiaco, UT, AU
Predictive Discovery Limited focuses on the exploration, discovery, and development of economically viable resource deposits across West Africa. The company's primary asset is the Bankan Gold project, a 356-square-kilometer site located in north-eastern Guinea, West Africa. Founded in 2007, this Australian-based firm operates from its headquarters in Subiaco.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +900.00% | +0.00% | +0.00% | +0.00% | +900.00% | -90.00% | -96.67% | -99.95% | -99.99% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Gold: +36.5%-43.8% Q1'21: +0.0% (vs Q1'20)
-
EPS growth Gold: +64.9%+0.0% Q1'21: +46.8% (vs Q1'20)
-
FCF margin FCF growth · Gold: +77.7%-280.7% Q1'21: -47.9% (vs Q1'20)
-
EBIT margin Gold: +25.8%-392.6% Q1'21: -100.5% (vs Q1'20)
-
ROIC Gold: +11.0%-153.7% Q1'21: -61.4% (vs Q1'20)
-
Share dilution Gold: -3.9%+9.3% Q1'21: +1.7% (vs Q1'20)
-
Debt / EBITDA Net debt/EBITDA · Gold: -0.09×-0.09× Q1'21: -0.68× (vs Q1'20)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 3 Rev. Ana. 2 EPS Ana. |
Jun 2027 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
65.71M
est.
|
91.37M
est.
|
910.15M
est.
|
1.17B
1.17B – 1.17B
+28.3% YoY
|
1.60B
1.60B – 1.60B
+37.1% YoY
|
| EBITDA |
-33.14M
est.
|
-46.08M
est.
|
-458.99M
est.
|
-588.92M
-588.92M – -588.92M
-28.3% YoY
|
-807.23M
-807.23M – -807.23M
-37.1% YoY
|
| EBIT |
-47.32M
est.
|
-65.80M
est.
|
-655.44M
est.
|
-840.99M
-840.99M – -840.99M
-28.3% YoY
|
-1.15B
-1.15B – -1.15B
-37.1% YoY
|
| Net Income |
—
est.
|
-1.54M
est.
|
5.81M
est.
|
27.57M
20.32M – 34.83M
+375.0% YoY
|
17.42M
17.42M – 17.42M
-36.8% YoY
|
| SGA |
67.16M
est.
|
93.39M
est.
|
930.29M
est.
|
1.19B
1.19B – 1.19B
+28.3% YoY
|
1.64B
1.64B – 1.64B
+37.1% YoY
|
| EPS |
—
est.
|
-0.01
est.
|
0.02
est.
|
0.10
0.07 – 0.12
+375.0% YoY
|
0.06
0.06 – 0.06
-36.8% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-04-09 | Sorrentino John | Director | A-Award | A | Common Stock Option | 2,000,000 | 0.20 | 400.0K | 4,000,000 | — | ↗ |
| 2021-04-09 | ROBINSON BRADLEY C | Director / Officer / 10% Owner | A-Award | A | Common Stock Options | 4,000,000 | 0.20 | 800.0K | 4,000,000 | — | ↗ |
| 2021-04-09 | Hatch Orrin | Director | A-Award | A | Common Stock Options | 250,000 | 0.20 | 50.0K | 500,000 | — | ↗ |
| 2021-04-09 | Easdale Jacob Andrew | Officer | — | D | Common Stock Option | 250,000 | 0.20 | 50.0K | 0 | — | ↗ |
| 2021-04-09 | EVANS PAUL S | Officer | A-Award | A | Common Stock Options | 250,000 | 0.20 | 50.0K | 2,250,000 | — | ↗ |
| 2021-04-09 | Dey Michael | Director | A-Award | A | Common Stock Options | 1,500,000 | 0.20 | 300.0K | 3,000,000 | — | ↗ |
| 2021-04-09 | Barhorst Ronald | Director | A-Award | A | Common Stock Options | 1,500,000 | 0.20 | 300.0K | 2,250,000 | — | ↗ |
| 2021-02-16 | Easdale Jacob Andrew | Officer | — | D | Common Stock Option | 250,000 | 0.12 | 30.0K | 0 | — | ↗ |
| 2019-11-28 | HERBERT MICHAEL E | Officer | — | D | Common Stock Option | 200,000 | 0.50 | 100.0K | 0 | — | ↗ |
| 2019-11-20 | ROBINSON BRADLEY C | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 0.84 | 8.4K | 20,010,000 | — | ↗ |
| 2019-04-09 | Sorrentino John | Director | — | D | Common Stock Options | 2,000,000 | 2.70 | 5.40M | 0 | — | ↗ |
| 2019-04-09 | Olson Eric K. | Officer | A-Award | A | Common Stock Options | 250,000 | 2.07 | 517.5K | 250,000 | — | ↗ |
| 2019-04-09 | MOYES JAY M | Director | — | D | Common Stock Options | 250,000 | 2.07 | 517.5K | 0 | — | ↗ |
| 2019-04-09 | Hatch Orrin | Director | — | D | Common Stock Options | 250,000 | 2.07 | 517.5K | 0 | — | ↗ |
| 2019-04-09 | HERBERT MICHAEL E | Officer | A-Award | A | Common Stock Options | 6,000,000 | 2.07 | 12.42M | 1,000,000 | — | ↗ |
| 2019-04-09 | EVANS PAUL S | Officer | A-Award | A | Common Stock Options | 1,000,000 | 2.07 | 2.07M | 2,000,000 | — | ↗ |
| 2019-04-09 | Dey Michael | Director | — | D | Common Stock Options | 450,000 | 2.07 | 931.5K | 0 | — | ↗ |
| 2019-04-09 | Brewer Simon | Officer | A-Award | A | Common Stock Options | 1,200,000 | 2.07 | 2.48M | 1,500,000 | — | ↗ |
| 2019-04-09 | Barhorst Ronald | Director | — | D | Common Stock Options | 750,000 | 2.07 | 1.55M | 0 | — | ↗ |
| 2019-04-01 | Lacy Tim | Officer | — | I | Stock Warrant | 2,400,000 | 0.50 | 1.20M | 0 | — | ↗ |
| 2019-03-19 | Barhorst Ronald | Director | — | D | Common Stock | 0 | 0.00 | — | 1,766,100 | — | ↗ |
| 2019-02-26 | ROBINSON BRADLEY C | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 22,492,482 | — | ↗ |
| 2019-02-26 | Olson Eric K. | Officer | — | D | Common Stock | 0 | 0.00 | — | 7,500,000 | — | ↗ |
| 2019-02-26 | EVANS PAUL S | Officer | — | I | Common Stock | 0 | 0.00 | — | 286,000 | — | ↗ |
| 2019-02-05 | Brewer Simon | Officer | — | D | Common Stock Option | 300,000 | 0.80 | 240.0K | 0 | — | ↗ |
| 2017-12-20 | EVANS PAUL S | Officer | — | D | Common Stock Option | 1,000,000 | 0.78 | 780.0K | 0 | — | ↗ |
| 2017-08-01 | Dey Michael | Director | — | D | Common Stock Options | 750,000 | 0.50 | 375.0K | 0 | — | ↗ |
| 2008-04-07 | Taplin Craig P | Director / Officer / 10% Owner | — | D | Common Stock, par value $0.001 | 0 | 0.00 | — | 11,900,000 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bradley C. Robinson | Chief Executive Officer, President & Director | 300.0K | male |
| Michael Dey | Chief Executive Officer of Predictive Therapeutics & Director | 10.0K | — |
| Bruce D. Forrest | Chief Development Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PREDQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
